Revance Therapeutics (RVNC)
(Delayed Data from NSDQ)
$2.71 USD
+0.04 (1.50%)
Updated May 24, 2024 04:00 PM ET
After-Market: $2.70 -0.01 (-0.37%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum D VGM
Earnings News For RVNC
-
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
-
Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
-
Revance Reports Fourth Quarter and Full Year 2023 Financial Results, Provides Corporate Update
-
Revance Reports Third Quarter 2023 Financial Results, Provides Corporate Update
-
Revance Therapeutics, Inc. (RVNC) Reports Q2 Loss, Tops Revenue Estimates
-
Revance Reports Second Quarter 2023 Financial Results, Provides Corporate Update
-
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates
-
Revance Reports First Quarter 2023 Financial Results, Provides Corporate Update
-
Revance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
-
Revance Therapeutics, Inc. (RVNC) Reports Q4 Loss, Tops Revenue Estimates
-
Revance Reports Fourth Quarter and Full Year 2022 Financial Results, Provides Corporate Update
-
Earnings Preview: Revance Therapeutics, Inc. (RVNC) Q4 Earnings Expected to Decline
-
Revance Therapeutics, Inc. (RVNC) Reports Q3 Loss, Tops Revenue Estimates
-
Revance Reports Third Quarter 2022 Financial Results, Provides Corporate Update
-
Revance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: Should You Buy?
-
Revance Therapeutics, Inc. (RVNC) Reports Q2 Loss, Tops Revenue Estimates
-
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates
-
Revance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
-
Revance Therapeutics, Inc. (RVNC) Reports Q3 Loss, Misses Revenue Estimates
-
Revance Therapeutics, Inc. (RVNC) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Revance Therapeutics, Inc. (RVNC) Reports Q2 Loss, Tops Revenue Estimates
-
Analysts Estimate Revance Therapeutics, Inc. (RVNC) to Report a Decline in Earnings: What to Look Out for
-
Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Tops Revenue Estimates
-
Earnings Preview: Revance Therapeutics, Inc. (RVNC) Q1 Earnings Expected to Decline
-
Will Revance Therapeutics (RVNC) Report Negative Q2 Earnings? What You Should Know